Krystal Biotech, Inc. (KRYS)
251.68
-6.32
(-2.45%)
USD |
NASDAQ |
Mar 20, 16:00
252.51
+0.83
(+0.33%)
Pre-Market: 09:08
Krystal Biotech Market Cap : 7.357B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.531B |
| Scholar Rock Holding Corp. | 5.128B |
| Alkermes Plc | 4.691B |
| Stoke Therapeutics, Inc. | 1.982B |
| Regeneron Pharmaceuticals, Inc. | 77.48B |
Market Cap Related Metrics
| PE Ratio | 36.77 |
| PS Ratio | 19.36 |
| PEG Ratio | 0.2849 |
| Price to Book Value | 6.033 |
| Price to Free Cash Flow | 39.87 |
| Price | 251.68 |
| Earnings Yield | 2.72% |
| PEGY Ratio | 0.2849 |
| Operating PE Ratio | 46.74 |
| Normalized PE Ratio | 36.77 |